Nothing Special   »   [go: up one dir, main page]

GB0524675D0 - Compounds - Google Patents

Compounds

Info

Publication number
GB0524675D0
GB0524675D0 GB0524675A GB0524675A GB0524675D0 GB 0524675 D0 GB0524675 D0 GB 0524675D0 GB 0524675 A GB0524675 A GB 0524675A GB 0524675 A GB0524675 A GB 0524675A GB 0524675 D0 GB0524675 D0 GB 0524675D0
Authority
GB
United Kingdom
Prior art keywords
compounds
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
GB0524675A
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Glaxo Group Ltd
Original Assignee
Glaxo Group Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Glaxo Group Ltd filed Critical Glaxo Group Ltd
Priority to GB0524675A priority Critical patent/GB0524675D0/en
Priority to UY29298A priority patent/UY29298A1/en
Priority to EA200801909A priority patent/EA200801909A1/en
Priority to MX2007007830A priority patent/MX2007007830A/en
Priority to EA200701324A priority patent/EA200701324A1/en
Priority to JP2007547393A priority patent/JP2008525363A/en
Priority to AU2005318372A priority patent/AU2005318372A1/en
Priority to EP09150218A priority patent/EP2053042A1/en
Priority to DE602005013116T priority patent/DE602005013116D1/en
Priority to US11/722,402 priority patent/US20100137378A1/en
Priority to PCT/EP2005/014061 priority patent/WO2006066968A1/en
Priority to CA002592442A priority patent/CA2592442A1/en
Priority to AT05817767T priority patent/ATE424386T1/en
Priority to TW094145424A priority patent/TW200640865A/en
Priority to BRPI0519398-2A priority patent/BRPI0519398A2/en
Priority to KR1020077014271A priority patent/KR20070091301A/en
Priority to EP05817767A priority patent/EP1833795B1/en
Priority to ES05817767T priority patent/ES2321535T3/en
Priority to ARP050105412A priority patent/AR052429A1/en
Priority to PE2006000025A priority patent/PE20060838A1/en
Publication of GB0524675D0 publication Critical patent/GB0524675D0/en
Priority to PE2008001431A priority patent/PE20081440A1/en
Priority to MA29966A priority patent/MA29082B1/en
Priority to IL183781A priority patent/IL183781A0/en
Priority to US11/766,418 priority patent/US7759369B2/en
Priority to NO20073332A priority patent/NO20073332L/en
Pending legal-status Critical Current

Links

GB0524675A 2004-12-23 2005-12-02 Compounds Pending GB0524675D0 (en)

Priority Applications (25)

Application Number Priority Date Filing Date Title
GB0524675A GB0524675D0 (en) 2005-12-02 2005-12-02 Compounds
TW094145424A TW200640865A (en) 2004-12-23 2005-12-21 Compounds
BRPI0519398-2A BRPI0519398A2 (en) 2004-12-23 2005-12-21 Pyridine Compounds for the Treatment of Prostaglandin-Mediated Diseases
EA200801909A EA200801909A1 (en) 2004-12-23 2005-12-21 PYRIDINE COMPOUNDS FOR THE TREATMENT OF DISEASES MEDIATED BY PROSTAGLANDINE
KR1020077014271A KR20070091301A (en) 2004-12-23 2005-12-21 Pyridine compounds for the treatment of prostaglandin mediated diseases
JP2007547393A JP2008525363A (en) 2004-12-23 2005-12-21 Pyridine compounds for the treatment of prostaglandin-mediated diseases
AU2005318372A AU2005318372A1 (en) 2004-12-23 2005-12-21 Pyridine compounds for the treatment of prostaglandin mediated diseases
EP09150218A EP2053042A1 (en) 2004-12-23 2005-12-21 Pyridine compounds for the treatment of prostaglandin mediated diseases
DE602005013116T DE602005013116D1 (en) 2004-12-23 2005-12-21 PYRIDINE COMPOUNDS FOR THE TREATMENT OF PROSTAGLANDIN-MEDIATED DISEASES
US11/722,402 US20100137378A1 (en) 2004-12-23 2005-12-21 Pyridine Compounds For The Treatment Of Prostaglandin Mediated Diseases
PCT/EP2005/014061 WO2006066968A1 (en) 2004-12-23 2005-12-21 Pyridine compounds for the treatment of prostaglandin mediated diseases
CA002592442A CA2592442A1 (en) 2004-12-23 2005-12-21 Pyridine compounds for the treatment of prostaglandin mediated diseases
AT05817767T ATE424386T1 (en) 2004-12-23 2005-12-21 PYRIDINE COMPOUNDS FOR THE TREATMENT OF PROSTAGLANDIN-MEDIATED DISEASES
UY29298A UY29298A1 (en) 2004-12-23 2005-12-21 COMPOUNDS
MX2007007830A MX2007007830A (en) 2004-12-23 2005-12-21 Pyridine compounds for the treatment of prostaglandin mediated diseases.
EA200701324A EA200701324A1 (en) 2004-12-23 2005-12-21 PYRIDINE COMPOUNDS FOR THE TREATMENT OF DISEASES MEDIATED BY PROSTAGLANDINE
EP05817767A EP1833795B1 (en) 2004-12-23 2005-12-21 Pyridine compounds for the treatment of prostaglandin mediated diseases
ES05817767T ES2321535T3 (en) 2004-12-23 2005-12-21 PIRIDINE COMPOUNDS FOR THE TREATMENT OF DISEASES MEDIATED BY PROSTAGLANDINAS.
ARP050105412A AR052429A1 (en) 2004-12-23 2005-12-21 ARILPIRIDINE COMPOSITE, PHARMACEUTICAL COMPOSITION THAT INCLUDES IT, ITS USE FOR THE PREPARATION OF A MEDICINAL PRODUCT AND PROCEDURE TO PREPARE IT
PE2006000025A PE20060838A1 (en) 2004-12-23 2006-01-03 6- [(5 - CHLORINE - 2 - {[(4-CHLORO-2-FLUOROPHENYL) METHYL] OXY} PHENYL) METHYL] -2-PYRIDINECARBOXYL ACID, SALTS OF IT, AS WELL AS COMPOSITIONS THAT INCLUDE IT
PE2008001431A PE20081440A1 (en) 2004-12-23 2006-01-30 PYRIDINE DERIVATIVES AS ANTAGONISTS OF EP1 PROSTAGLANDIN RECEPTORS
MA29966A MA29082B1 (en) 2004-12-23 2007-06-06 PYRIDINE COMPOUNDS FOR THE TREATMENT OF PROSTAGLANDIN-MEDIATED DISEASES
IL183781A IL183781A0 (en) 2004-12-23 2007-06-07 Pyridine compounds for the treatment of prostaglandin mediated diseases
US11/766,418 US7759369B2 (en) 2004-12-23 2007-06-21 Pyridine compounds for the treatment of prostaglandin mediated diseases
NO20073332A NO20073332L (en) 2004-12-23 2007-06-28 Pyridine compounds for the treatment of prostaglandin-mediated diseases

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB0524675A GB0524675D0 (en) 2005-12-02 2005-12-02 Compounds

Publications (1)

Publication Number Publication Date
GB0524675D0 true GB0524675D0 (en) 2006-01-11

Family

ID=35686004

Family Applications (1)

Application Number Title Priority Date Filing Date
GB0524675A Pending GB0524675D0 (en) 2004-12-23 2005-12-02 Compounds

Country Status (1)

Country Link
GB (1) GB0524675D0 (en)

Similar Documents

Publication Publication Date Title
GB0508472D0 (en) Compounds
GB0503962D0 (en) Compounds
GB0507602D0 (en) Compounds
GB0502418D0 (en) Compounds
GB0502316D0 (en) Compounds
EP1961741A4 (en) m-CARBAZOLYLPHENYL COMPOUNDS
GB0508463D0 (en) Compounds
GB0502299D0 (en) Compounds
GB0502310D0 (en) Compounds
GB0503961D0 (en) Compounds
AP2007004220A0 (en) Motilide compounds
GB0505084D0 (en) Compounds
EP1907385A4 (en) Compounds
GB0506467D0 (en) Compounds
GB0505086D0 (en) Compounds
GB0508460D0 (en) Compounds
GB0505509D0 (en) Compounds
GB0505735D0 (en) Compounds
GB0501985D0 (en) Compounds
EP1867650A4 (en) Hydroxymethylboron compounds
GB0505085D0 (en) Compounds
GB0501984D0 (en) Compounds
GB0503145D0 (en) Compounds
GB0501839D0 (en) Compounds
GB0500892D0 (en) Compounds